Deltex Medical (GB:DEMG) has released an update.
Deltex Medical Group PLC has announced that investor Michael Stubbs has increased his stake in the company to 5.51%, following a recent purchase of shares. The company also highlighted advancements in its proprietary haemodynamic monitoring technology, including a new non-invasive device that broadens potential applications across healthcare settings. These innovations aim to improve patient outcomes and hospital efficiency, and are expected to generate recurring revenue streams for Deltex Medical.
For further insights into GB:DEMG stock, check out TipRanks’ Stock Analysis page.
